![(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F319814-1s-15-anhydro-1-c-4-chloro-3-4-ethoxyphenyl-methyl-phenyl-d-glucitol-s-propane-12-diol-1-1-monohydrate.webp&w=3840&q=75)
CAS 960404-48-2
:(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate
Formule :C21H25ClO6·C3H8O2·H2O
InChI :InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
Code InChI :InChIKey=GOADIQFWSVMMRJ-UPGAGZFNSA-N
SMILES :O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2.[C@@H](CO)(C)O.O
Synonymes :- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol (S)-propane-1,2-diol (1:1) monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- Dapagliflozin (S)-propylene glycol hydrate
- Dapagliflozin Propylene Glycolate Hydrate
- Edistride
- Farxiga
- Forxiga
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
13 produits trouvés.
Dapagliflozin Propanediol
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C21H25ClO6·C3H8O2·H2OCouleur et forme :White Off-White PowderMasse moléculaire :502.19696Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS :Dapagliflozin ((2S)-1,2-propanediol, hydrate)Formule :C24H35ClO9Degré de pureté :≥98%Masse moléculaire :502.98D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
CAS :Formule :C24H35ClO9Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :502.9823Ref: IN-DA00IMNP
1kgÀ demander5kgÀ demander100mg26,00€1g27,00€250mg30,00€5g40,00€25g84,00€100g208,00€500g688,00€Dapagliflozin propanediol monohydrate
CAS :Formule :C21H25ClO6·C3H8O2·H2ODegré de pureté :≥ 98.0%Couleur et forme :White to yellow or beige powder or solidMasse moléculaire :502.98Dapagliflozin Propanediol Hydrate
CAS :Dapagliflozin Propanediol HydrateDegré de pureté :99%Masse moléculaire :502.98g/molDapagliflozin (2S)-1,2-Propanediol Monohydrate
CAS :Formule :C21H25ClO6·C3H8O2·H2OCouleur et forme :NeatMasse moléculaire :502.98Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS :Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-Formule :C24H35ClO9Degré de pureté :99.88% - 99.94%Couleur et forme :SolidMasse moléculaire :502.98Dapagliflozin Propanediol Monohydrate
CAS :Formule :C21H25ClO6C3H8O2H2OMasse moléculaire :408.88 : 76.09 : 18.0(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE
CAS :Degré de pureté :95%Masse moléculaire :502.989990234375Dapagliflozin Propanediol Hydrate
CAS :Formule :C21H25ClO6·C3H8O2·H2OCouleur et forme :NeatMasse moléculaire :502.98Dapagliflozin propanediol monohydrate - Bio-X ™
CAS :Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. It inhibits glucose reabsorption in the proximal tubule of the nephron and results in glycosuria, which helps to improve glycaemic control. Also, Dapagliflozin is used to lower the risk of sustained eGFR decline, end-stage renal disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease who are at risk of progression.Formule :C21H25ClO6•C3H8O2•H2ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :502.98 g/molDapagliflozin propanediol monohydrate
CAS :Dapagliflozin is an oral antidiabetic drug that acts by inhibiting the SGLT2 enzyme. The SGLT2 enzyme is responsible for reabsorbing glucose from the kidney, so by inhibiting this enzyme, glucose will be excreted in the urine and blood glucose levels will decrease. Dapagliflozin also has a low bioavailability in vivo, which can be improved by administration with food. This drug has been shown to have a longer elimination half-life than canagliflozin and empagliflozin. Dapagliflozin has been shown to have a higher potency than metformin hydrochloride in vitro.Formule :C24H35ClO9Degré de pureté :(Hplc) Min. 99.0%Couleur et forme :PowderMasse moléculaire :502.98 g/mol
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00IMNP.jpg&w=3840&q=75)
